John Pernow

13.2k total citations
272 papers, 10.3k citations indexed

About

John Pernow is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, John Pernow has authored 272 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Physiology, 118 papers in Cardiology and Cardiovascular Medicine and 69 papers in Molecular Biology. Recurrent topics in John Pernow's work include Nitric Oxide and Endothelin Effects (121 papers), Neuropeptides and Animal Physiology (53 papers) and Cardiac Ischemia and Reperfusion (51 papers). John Pernow is often cited by papers focused on Nitric Oxide and Endothelin Effects (121 papers), Neuropeptides and Animal Physiology (53 papers) and Cardiac Ischemia and Reperfusion (51 papers). John Pernow collaborates with scholars based in Sweden, Germany and United States. John Pernow's co-authors include Jan M. Lundberg, Felix Böhm, Christian Jung, Adrian Gonon, Qing‐Dong Wang, Alexey Shemyakin, Anette Hemsén, Elvar Theodorsson, Magnus Settergren and Jon O. Lundberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

John Pernow

269 papers receiving 10.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
John Pernow	3.9k	3.5k	3.0k	2.3k	1.8k	272	10.3k
Masaki Nakane	5.7k 1.4×	1.8k 0.5×	3.0k 1.0×	2.0k 0.9×	739 0.4×	144	10.7k
Paul M. Vanhoutte	8.2k 2.1×	5.1k 1.5×	3.6k 1.2×	1.4k 0.6×	2.1k 1.2×	279	15.1k
Eliot H. Ohlstein	3.4k 0.9×	3.9k 1.1×	3.5k 1.2×	739 0.3×	2.2k 1.2×	198	10.8k
Philip J. Kadowitz	3.9k 1.0×	2.5k 0.7×	3.5k 1.2×	2.2k 1.0×	1.7k 0.9×	475	12.4k
Maik Gollasch	2.2k 0.6×	3.1k 0.9×	3.3k 1.1×	1.2k 0.5×	1.7k 0.9×	187	8.5k
Jean‐Luc Balligand	5.7k 1.4×	5.3k 1.5×	5.3k 1.8×	692 0.3×	1.5k 0.8×	182	13.1k
Michel Félétou	6.2k 1.6×	3.3k 0.9×	2.9k 1.0×	808 0.4×	1.2k 0.7×	134	10.8k
Pramod R. Saxena	2.6k 0.7×	2.6k 0.7×	2.3k 0.8×	1.6k 0.7×	693 0.4×	220	8.3k
Gabor M. Rubanyi	6.6k 1.7×	4.4k 1.3×	3.5k 1.2×	761 0.3×	1.7k 0.9×	173	13.2k
Zvonimir S. Katušić	5.6k 1.4×	2.9k 0.8×	3.7k 1.2×	625 0.3×	1.2k 0.6×	230	11.9k

Countries citing papers authored by John Pernow

Since Specialization

Citations

This map shows the geographic impact of John Pernow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pernow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pernow more than expected).

Fields of papers citing papers by John Pernow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Pernow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pernow. The network helps show where John Pernow may publish in the future.

Co-authorship network of co-authors of John Pernow

This figure shows the co-authorship network connecting the top 25 collaborators of John Pernow. A scholar is included among the top collaborators of John Pernow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Pernow. John Pernow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hussain, Shafaat, Abdul Waheed Khan, Liang Zhang, et al.. (2024). Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium. Cardiovascular Diabetology. 23(1). 122–122. 13 indexed citations

Jiao, Tong, Ulf Hedin, Zhichao Zhou, et al.. (2024). Red blood cells from patients with ST-elevation myocardial infarction and elevated C-reactive protein levels induce endothelial dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 327(6). H1431–H1441.

Chernogubova, Ekaterina, Michael Alvarsson, Lars Mäegdefessel, et al.. (2024). Red blood cells as potential materials for microRNA biomarker study: overcoming heparin-related challenges. American Journal of Physiology-Heart and Circulatory Physiology. 327(5). H1296–H1302.

Collado, Aida, Jiangning Yang, Michael Alvarsson, et al.. (2024). Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase. Clinical Science. 138(15). 975–985. 2 indexed citations

Mahdi, Ali, Ashwin Venkateshvaran, Henrike Häbel, et al.. (2023). Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia. Atherosclerosis. 389. 117439–117439. 5 indexed citations

Jiao, Tong, Aida Collado, Ali Mahdi, et al.. (2023). Stimulation of soluble guanylyl cyclase in erythrocytes induces export of cGMP and cardioprotection in type 2 diabetes. European Heart Journal. 44(Supplement_2). 1 indexed citations

Mahdi, Ali, Oskar Kövamees, Allan Z. Zhao, et al.. (2022). The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia. Journal of Internal Medicine. 293(2). 228–245. 14 indexed citations

Kjellberg, Anders, Carl Johan Sundberg, John Pernow, et al.. (2022). Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial. BMJ Open. 12(11). e061870–e061870. 15 indexed citations

Mahdi, Ali, Jannike Nickander, Artur Fedorowski, et al.. (2022). Abstract 12760: Microvascular Endothelial Dysfunction in Postural Orthostatic Tachycardia Syndrome Associated With Post-Acute Sequelae of COVID-19. Circulation. 146(Suppl_1). 1 indexed citations

10.

Verouhis, Dinos, Felix Böhm, Per Eriksson, et al.. (2021). Arginase 1 is upregulated at admission in patients with ST‐elevation myocardial infarction. Journal of Internal Medicine. 290(5). 1061–1070. 9 indexed citations

11.

Mahdi, Ali, Tong Jiao, Yahor Tratsiakovich, et al.. (2021). Therapeutic Potential of Sunitinib in Ameliorating Endothelial Dysfunction in Type 2 Diabetic Rats. Pharmacology. 107(3-4). 160–166. 4 indexed citations

12.

Lundberg, Johan, Per Nordberg, Björn Wieslander, et al.. (2020). The effect of levosimendan on survival and cardiac performance in an ischemic cardiac arrest model – A blinded randomized placebo-controlled study in swine. Resuscitation. 150. 113–120. 8 indexed citations

13.

Hussain, Shafaat, Abdul Waheed Khan, Alexander Akhmedov, et al.. (2020). Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD. Circulation Research. 127(10). 1261–1273. 47 indexed citations

14.

Prescott, Eva, John Pernow, Antti Saraste, et al.. (2020). Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction. Contemporary Clinical Trials Communications. 19. 100629–100629. 9 indexed citations

15.

Fröbert, Ole, et al.. (2019). Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events. Open Heart. 6(2). e001109–e001109. 3 indexed citations

16.

Zhou, Zhichao, Takayuki Matsumoto, Vera Jankowski, et al.. (2018). Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update. Pharmacological Research. 141. 32–45. 27 indexed citations

17.

Zhou, Zhichao, Ihsan Chrifi, Yanjuan Xu, et al.. (2016). Uridine adenosine tetraphosphate acts as a proangiogenic factor in vitro through purinergic P2Y receptors. American Journal of Physiology-Heart and Circulatory Physiology. 311(1). H299–H309. 15 indexed citations

18.

Shemyakin, Alexey, Oskar Kövamees, Arnar Rafnsson, et al.. (2012). Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus. Circulation. 126(25). 2943–2950. 154 indexed citations

19.

Settergren, Magnus, Felix Böhm, Rickard E. Malmström, Keith M. Channon, & John Pernow. (2008). L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease. European Heart Journal. 29. 714–714. 1 indexed citations

20.

Pernow, John, et al.. (2003). ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men. Clinical Science. 104(2). 143–143. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact